@misc{indiciaefa0789c6c56b,
  title = {The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate.},
  author = {C P Evans and V Gajendran and A Tewari and K Aslam and R Juster and S Gange and A Eason and P Narayan},
  year = {1996},
  doi = {10.1046/j.1464-410x.1996.00079.x},
  url = {https://pubmed.ncbi.nlm.nih.gov/8881955/},
  note = {Source identifier: 8881955}
}